Evidence map›Paper›PMID 40144462›Full record

ArticleOphthalmology science

Association of Retinal Oximetry with Peripheral Diabetic Retinopathy Lesions and Nonperfusion on Ultra-widefield Angiography.

Konstantina Sampani, Mohamed Ashraf, Cloyd M Pitoc, Jae Rhee, Ann M Tolson, Jerry D Cavallerano, Jennifer K Sun, Lloyd Paul Aiello, Paolo S Silva

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Konstantina SampaniBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Mohamed AshrafBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Cloyd M PitocPhilippine Eye Research Institute, University of the Philippines, Manila, Philippines.
Jae RheeBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Ann M TolsonBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Jerry D CavalleranoBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Jennifer K SunBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Lloyd Paul AielloBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
Paolo S SilvaBeetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

Purpose: To evaluate the association of retinal ischemia measured using retinal oximetry with retinal nonperfusion and predominantly peripheral lesions on ultra-widefield (UWF) fluorescein angiography (FA PPL). Design: Prospective single-center, image evaluation study. Participants: Images from 42 eyes from 21 participants with diabetes. Methods: Ultra-widefield images were evaluated to determine diabetic retinopathy (DR) severity. Ultra-widefield FA images were used to measure nonperfusion area (NPA, mm Main Outcome Measures: Nonperfusion area, NPI, and presence of FA PPL. Results: Mean age was 40.7 ± 10.4 years, diabetes duration 21.4 ± 10.0 years, hemoglobin A1c (HbA1c) 7.7 ± 1.0, 33.3% (14) were female, and 76.2% (32) had type 1. Distribution of DR on UWF color imaging was no-DR 9.5% (4); mild 45.2% (19), moderate 21.4% (9), and severe 9.5% (4) nonproliferative DR; and proliferative DR 14.3 (6) with FA PPL present in 25 (59.5%). Mean NPA/NPI was associated with increasing DR severity ( Conclusions: Past studies have established an increased risk of DR progression with the presence of FA PPL. These data show that FA PPL presence is associated with retinal oximetry measures consistent with the presence of venous shunting or reduced retinal oxygen consumption, possibly indicative of greater areas of retinal ischemia. These findings highlight the value of retinal oximetry as a noninvasive measure of retinal ischemia and as a potential marker for increased risk of DR worsening. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Diabetic retinopathyRetinal ischemiaRetinal nonperfusionRetinal oximetryUltra-widefield angiography

Identifiers

PMID40144462
PMCPMC11937658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.